Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 182

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

A comprehensive analysis and annotation of human normal urinary proteome

Open access
Zhao, Mindi, Li, Menglin, Yang, Yehong, Guo, Zhengguang, Sun, Ying, Shao, Chen, Li, Mingxi, Sun, Wei, Gao, Youhe · 2017 · Scientific Reports

Abstract

Biomarkers are measurable changes associated with the disease. Urine can reflect the changes of the body while blood is under control of the homeostatic mechanisms; thus, urine is considered an important source for early and sensitive disease biomarker discovery. A comprehensive profile of the urinary proteome will provide a basic understanding of urinary proteins. In this paper, we present an in-depth analysis of the urinary proteome based on different separation strategies, including direct one dimensional liquid chromatography–tandem mass spectrometry (LC/MS/MS), two dimensional LC/MS/MS, and gel-eluted liquid fraction entrapment electrophoresis/liquid-phase isoelectric focusing followed by two dimensional LC/MS/MS. A total of 6085 proteins were identified in healthy urine, of which 2001 were not reported in previous studies and the concentrations of 2571 proteins were estimated (spanning a magnitude of 10 6) with an intensity-based absolute quantification algorithm. The urinary proteins were annotated by their tissue distribution. Detailed information can be accessed at the “Human Urine Proteome Database” (www.urimarker.com/urine).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-03226-6

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 88

  1. Casey, H. W., Ayers, K. N. & Robinson, F. In Pathology of laboratory animals 115–173 (Springer, 1978). · doi:10.1007/978-1-4612-9942-4_3
  2. Gao, Y. Urine-an untapped goldmine for biomarker discovery? Science China. Life sciences 56, 1145–1146, doi:10.1007/s11427-013-4574-1 (2013). · DOI · Paper page
  3. Sun, W. et al. Human urine proteome analysis by three separation approaches. Proteomics 5, 4994–5001, doi:10.1002/pmic.200401334 (2005). · DOI
  4. Ho, J. et al. Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study. American journal of kidney diseases: the official journal of the National Kidney Foundation 53, 584–595, doi:10.1053/j.ajkd.2008.10.037 (2009). · DOI · Paper page
  5. Orenes-Pinero, E. et al. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach. Journal of proteome research 6, 4440–4448, doi:10.1021/pr070368w (2007). · doi:10.1021/pr070368w
  6. Zubiri, I. et al. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. Journal of proteomics 96, 92–102, doi:10.1016/j.jprot.2013.10.037 (2014). · DOI · Paper page
  7. Liu, L. et al. Evaluation of urinary S100B protein level and lactate/creatinine ratio for early diagnosis and prognostic prediction of neonatal hypoxic-ischemic encephalopathy. Neonatology 97, 41–44, doi:10.1159/000227292 (2010). · doi:10.1159/000227292
  8. Chugh, S. et al. Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure. Proteomics 13, 2324–2334, doi:10.1002/pmic.201200455 (2013). · DOI
  9. Davis, M. T. et al. Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. II. Limitations of complex mixture analyses. Proteomics 1, 108–117, doi:10.1002/1615-9861(200101)1:1<108::AID-PROT108>3.0.CO;2-5 (2001). · doi:10.1002/1615-9861(200101)1:1<108::aid-prot108>3.0.co;2-5
  10. Spahr, C. S. et al. Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. Proteomics 1, 93–107, doi:10.1002/1615-9861(200101)1:1<93::AID-PROT93>3.0.CO;2-3 (2001). · DOI · Paper page
  11. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V. & Mann, M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome biology 7, R80, doi:10.1186/gb-2006-7-9-R80 (2006). · DOI · Paper page
  12. Marimuthu, A. et al. A comprehensive map of the human urinary proteome. Journal of proteome research 10, 2734–2743, doi:10.1021/pr2003038 (2011). · DOI · Paper page
  13. Li, Q. R. et al. A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine. Rapid communications in mass spectrometry: RCM 24, 823–832, doi:10.1002/rcm.4441 (2010). · DOI
  14. Zheng, J., Liu, L., Wang, J. & Jin, Q. Urinary proteomic and non-prefractionation quantitative phosphoproteomic analysis during pregnancy and non-pregnancy. BMC genomics 14, 777, doi:10.1186/1471-2164-14-777 (2013). · DOI
  15. Santucci, L. et al. From hundreds to thousands: Widening the normal human Urinome (1). Journal of proteomics 112C, 53–62, doi:10.1016/j.jprot.2014.07.021 (2014). · DOI
  16. Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74, doi:10.1038/nature11247 (2012). · DOI · Paper page
  17. Ahmed, F. E. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry. Journal of separation science 32, 771–798, doi:10.1002/jssc.200800622 (2009). · DOI
  18. Wang, Z., Hill, S., Luther, J. M., Hachey, D. L. & Schey, K. L. Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT). Proteomics 12, 329–338, doi:10.1002/pmic.201100477 (2012). · DOI · Paper page
  19. Hogan, M. C. et al. Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine. Kidney international 85, 1225–1237, doi:10.1038/ki.2013.422 (2014). · DOI
  20. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 4, 44–57, doi:10.1038/nprot.2008.211 (2009). · DOI · Paper page
  21. Huang da, W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research 37, 1–13, doi:10.1093/nar/gkn923 (2009). · DOI · Paper page
  22. Jia, L. et al. An attempt to understand kidney’s protein handling function by comparing plasma and urine proteomes. PloS one 4, e5146, doi:10.1371/journal.pone.0005146 (2009). · DOI
  23. Farrah, T. et al. State of the human proteome in 2013 as viewed through PeptideAtlas: comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven Human Proteome Project. Journal of proteome research 13, 60–75, doi:10.1021/pr4010037 (2014). · DOI
  24. Pieper, R. et al. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 4, 1159–1174, doi:10.1002/pmic.200300661 (2004). · DOI · Paper page
  25. Nagaraj, N. & Mann, M. Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. Journal of proteome research 10, 637–645, doi:10.1021/pr100835s (2011). · DOI · Paper page
  26. Dyer, A. R. et al. Evaluation of measures of urinary albumin excretion in epidemiologic studies. American journal of epidemiology 160, 1122–1131, doi:10.1093/aje/kwh326 (2004). · DOI
  27. Nolen, B. M. et al. An extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors. PloS one 8, e63368, doi:10.1371/journal.pone.0063368 (2013). · doi:10.1371/journal.pone.0063368
  28. Kentsis, A. et al. Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry. Annals of emergency medicine 55, 62–70 e64, doi:10.1016/j.annemergmed.2009.04.020 (2010). · DOI
  29. Shao, C., Wang, Y. & Gao, Y. Applications of urinary proteomics in biomarker discovery. Science China. Life sciences 54, 409–417, doi:10.1007/s11427-011-4162-1 (2011). · DOI
  30. Suh, J. H. & Miner, J. H. The glomerular basement membrane as a barrier to albumin. Nature reviews. Nephrology 9, 470–477, doi:10.1038/nrneph.2013.109 (2013). · DOI · Paper page
  31. Welsh, G. I. & Saleem, M. A. The podocyte cytoskeleton–key to a functioning glomerulus in health and disease. Nature reviews. Nephrology 8, 14–21, doi:10.1038/nrneph.2011.151 (2012). · DOI · Paper page
  32. Schwarz, K. et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. The Journal of clinical investigation 108, 1621–1629, doi:10.1172/JCI12849 (2001). · DOI · Paper page
  33. Vaidya, V. S., Ferguson, M. A. & Bonventre, J. V. Biomarkers of acute kidney injury. Annual review of pharmacology and toxicology 48, 463–493, doi:10.1146/annurev.pharmtox.48.113006.094615 (2008). · DOI · Paper page
  34. Beck, L. H. Jr. et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. The New England journal of medicine 361, 11–21, doi:10.1056/NEJMoa0810457 (2009). · DOI · Paper page
  35. Wei, C. et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nature medicine 17, 952–960, doi:10.1038/nm.2411 (2011). · DOI · Paper page
  36. Flint, R. S. et al. Probing the urinary proteome of severe acute pancreatitis. HPB: the official journal of the International Hepato Pancreato Biliary Association 9, 447–455, doi:10.1080/13651820701721744 (2007). · DOI
  37. Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419, doi:10.1126/science.1260419 (2015). · DOI · Paper page
  38. Cargile, B. J., Sevinsky, J. R., Essader, A. S., Eu, J. P. & Stephenson, J. L. Jr. Calculation of the isoelectric point of tryptic peptides in the pH 3.5–4.5 range based on adjacent amino acid effects. Electrophoresis 29, 2768–2778, doi:10.1002/elps.200700701 (2008). · doi:10.1002/elps.200700701
  39. Rabilloud, T. et al. Power and limitations of electrophoretic separations in proteomics strategies. Mass spectrometry reviews 28, 816–843, doi:10.1002/mas.20204 (2009). · DOI
  40. Vaezzadeh, A. R., Briscoe, A. C., Steen, H. & Lee, R. S. One-step sample concentration, purification, and albumin depletion method for urinary proteomics. Journal of proteome research 9, 6082–6089, doi:10.1021/pr100924s (2010). · DOI
  41. Guldbrandsen, A. et al. In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR). Molecular & cellular proteomics: MCP 13, 3152–3163, doi:10.1074/mcp.M114.038554 (2014). · DOI · Paper page
  42. Wang, Y. et al. Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics 11, 2019–2026, doi:10.1002/pmic.201000722 (2011). · DOI · Paper page
  43. Nesvizhskii, A. I., Keller, A., Kolker, E. & Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Analytical chemistry 75, 4646–4658 (2003). · DOI · Paper page
  44. Hauck, S. M. et al. Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry. Molecular & cellular proteomics: MCP 9, 2292–2305, doi:10.1074/mcp.M110.001073 (2010). · DOI · Paper page
  45. Satoskar, A. A. et al. Characterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 25, 709–721, doi:10.1038/modpathol.2011.205 (2012). · DOI
  46. Skoberne, A., Konieczny, A. & Schiffer, M. Glomerular epithelial cells in the urine: what has to be done to make them worthwhile? American journal of physiology. Renal physiology 296, F230–241, doi:10.1152/ajprenal.90507.2008 (2009). · DOI
  47. Fukuda, H. et al. Podocin is translocated to cytoplasm in puromycin aminonucleoside nephrosis rats and in poor-prognosis patients with IgA nephropathy. Cell and tissue research 360, 391–400, doi:10.1007/s00441-014-2100-9 (2015). · DOI
  48. Mansour, H. et al. T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome. Kidney international 67, 2168–2177, doi:10.1111/j.1523-1755.2005.00322.x (2005). · doi:10.1111/j.1523-1755.2005.00322.x
  49. Kimura, M. et al. Expression of alpha-actinin-4 in human diabetic nephropathy. Internal medicine 47, 1099–1106 (2008). · DOI
  50. Kaplan, J. M. et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nature genetics 24, 251–256, doi:10.1038/73456 (2000). · DOI · Paper page
  51. Kubiak-Wlekly, A. et al. The Comparison of the Podocyte Expression of Synaptopodin, CR1 and Neprilysin in Human Glomerulonephritis: Could the Expression of CR1 be Clinically Relevant? International journal of biomedical science: IJBS 5, 28–36 (2009). · doi:10.59566/ijbs.2009.5028
  52. Johnstone, D. B. et al. Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy. Molecular and cellular biology 31, 2162–2170, doi:10.1128/MCB.05234-11 (2011). · DOI
  53. Yard, B. A. et al. Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium. Experimental nephrology 9, 214–222, doi:52614 (2001). · DOI
  54. Joosten, S. A. et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 5, 383–393, doi:10.1111/j.1600-6143.2005.00690.x (2005). · DOI
  55. Kashtan, C. E. & Kim, Y. Distribution of the alpha 1 and alpha 2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney international 42, 115–126 (1992). · doi:10.1038/ki.1992.269
  56. Kim, Y. et al. Differential expression of basement membrane collagen chains in diabetic nephropathy. The American journal of pathology 138, 413–420 (1991).
  57. Kim, Y. et al. Differential expression of basement membrane collagen in membranous nephropathy. The American journal of pathology 139, 1381–1388 (1991).
  58. Setty, S. et al. Differential expression of laminin isoforms in diabetic nephropathy and other renal diseases. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 25, 859–868, doi:10.1038/modpathol.2011.216 (2012). · DOI
  59. Jim, B. et al. Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PloS one 7, e36041, doi:10.1371/journal.pone.0036041 (2012). · DOI · Paper page
  60. Kim, J. M. et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300, 1298–1300, doi:10.1126/science.1081068 (2003). · DOI · Paper page
  61. Ye, H. et al. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy. Journal of diabetes and its complications 28, 96–100, doi:10.1016/j.jdiacomp.2013.08.006 (2014). · DOI
  62. Tufro, A. & Veron, D. VEGF and podocytes in diabetic nephropathy. Seminars in nephrology 32, 385–393, doi:10.1016/j.semnephrol.2012.06.010 (2012). · DOI
  63. El-Koraie, A. F., Baddour, N. M., Adam, A. G., El-Kashef, E. H. & El Nahas, A. M. Cytoskeletal protein expression and regenerative markers in schistosomal nephropathy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 17, 803–812 (2002). · doi:10.1093/ndt/17.5.803
  64. Birmingham, D. J. et al. Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare. Clinical journal of the American Society of Nephrology: CJASN 11, 47–53, doi:10.2215/CJN.03990415 (2016). · DOI
  65. Ilhan, N., Kahraman, N., Seckin, D., Ilhan, N. & Colak, R. Apo E gene polymorphism on development of diabetic nephropathy. Cell biochemistry and function 25, 527–532, doi:10.1002/cbf.1348 (2007). · DOI
  66. Fugmann, T. et al. Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy. Kidney international 80, 272–281, doi:10.1038/ki.2011.116 (2011). · DOI
  67. Wang, Q. Z. et al. Cofilin1 is involved in hypertension-induced renal damage via the regulation of NF-kappaB in renal tubular epithelial cells. Journal of translational medicine 13, 323, doi:10.1186/s12967-015-0685-8 (2015). · DOI
  68. Castelletti, F. et al. Mutations in FN1 cause glomerulopathy with fibronectin deposits. Proceedings of the National Academy of Sciences of the United States of America 105, 2538–2543, doi:10.1073/pnas.0707730105 (2008). · DOI
  69. Hanamura, K. et al. Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Human pathology 42, 649–658, doi:10.1016/j.humpath.2010.08.020 (2011). · doi:10.1016/j.humpath.2010.08.020
  70. Bonventre, J. V., Vaidya, V. S., Schmouder, R., Feig, P. & Dieterle, F. Next-generation biomarkers for detecting kidney toxicity. Nature biotechnology 28, 436–440, doi:10.1038/nbt0510-436 (2010). · DOI · Paper page
  71. Goligorsky, M. S., Addabbo, F. & O’Riordan, E. Diagnostic potential of urine proteome: a broken mirror of renal diseases. Journal of the American Society of Nephrology: JASN 18, 2233–2239, doi:10.1681/ASN.2006121399 (2007). · doi:10.1681/asn.2006121399
  72. Vaidya, V. S. & Bonventre, J. V. Mechanistic biomarkers for cytotoxic acute kidney injury. Expert opinion on drug metabolism & toxicology 2, 697–713, doi:10.1517/17425255.2.5.697 (2006). · DOI
  73. Trof, R. J., Di Maggio, F., Leemreis, J. & Groeneveld, A. B. Biomarkers of acute renal injury and renal failure. Shock 26, 245–253, doi:10.1097/01.shk.0000225415.5969694.ce (2006). · DOI · Paper page
  74. Gal-Yam, E. N., Saito, Y., Egger, G. & Jones, P. A. Cancer epigenetics: modifications, screening, and therapy. Annual review of medicine 59, 267–280, doi:10.1146/annurev.med.59.061606.095816 (2008). · DOI · Paper page
  75. Thrailkill, K. M. et al. Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin. Diabetes care 32, 1266–1268, doi:10.2337/dc09-0112 (2009). · DOI
  76. Schaub, J. A. et al. Perioperative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery. Kidney international 88, 576–583, doi:10.1038/ki.2015.104 (2015). · doi:10.1038/ki.2015.104
  77. Wu, I. & Parikh, C. R. Screening for kidney diseases: older measures versus novel biomarkers. Clinical journal of the American Society of Nephrology: CJASN 3, 1895–1901, doi:10.2215/CJN.02030408 (2008). · DOI
  78. Ricci, Z. & Ronco, C. Year in review: Critical Care 2004 - nephrology. Critical care 9, 523–527, doi:10.1186/cc3791 (2005). · doi:10.1186/cc3791
  79. Iida, T. et al. Decreased urinary calbindin 1 levels in proteinuric rats and humans with distal nephron segment injuries. Clinical and experimental nephrology 18, 432–443, doi:10.1007/s10157-013-0835-3 (2014). · doi:10.1007/s10157-013-0835-3
  80. Sawai, K. et al. Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney. American journal of physiology. Renal physiology 293, F1363–1372, doi:10.1152/ajprenal.00205.2007 (2007). · DOI · Paper page
  81. Lameire, N., Van Biesen, W. & Vanholder, R. Acute renal failure. Lancet 365, 417–430, doi:10.1016/S0140-6736(05)17831-3 (2005). · doi:10.1016/s0140-6736(05)70238-5 · Paper page
  82. Nuyts, G. D. et al. Human urinary intestinal alkaline phosphatase as an indicator of S3-segment-specific alterations in incipient diabetic nephropathy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 9, 377–381 (1994).
  83. Adiyanti, S. S. & Loho, T. Acute Kidney Injury (AKI) biomarker. Acta medica Indonesiana 44, 246–255 (2012).
  84. Ramesh, G., Kwon, O. & Ahn, K. Netrin-1: a novel universal biomarker of human kidney injury. Transplantation proceedings 42, 1519–1522, doi:10.1016/j.transproceed.2009.11.040 (2010). · DOI
  85. Mishra, J. et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365, 1231–1238, doi:10.1016/S0140-6736(05)74811-X (2005). · DOI · Paper page
  86. Yu, X. Q. et al. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. Kidney international 58, 1469–1480, doi:10.1046/j.1523-1755.2000.00309.x (2000). · doi:10.1046/j.1523-1755.2000.00309.x
  87. Liu, Y. et al. Urinary interleukin 18 for detection of acute kidney injury: a meta-analysis. American journal of kidney diseases: the official journal of the National Kidney Foundation 62, 1058–1067, doi:10.1053/j.ajkd.2013.05.014 (2013). · DOI
  88. Varghese, S. A. et al. Identification of diagnostic urinary biomarkers for acute kidney injury. Journal of investigative medicine: the official publication of the American Federation for Clinical Research 58, 612–620, doi:10.231/JIM.0b013e3181d473e7 (2010). · DOI

Cited by

See all 182

Metadata

Authors
Zhao, M., Li, M., Yang, Y., Guo, Z., Sun, Y., Shao, C., Li, M., Sun, W., & Gao, Y.
Venue
Scientific Reports
Published
2017-06-08
Volume
7
Issue
1
Pages
3024-3024
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2621092333
Cited by
182
References
10
FWCI
7.93
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A comprehensive analysis and annotation of human normal urinary proteome. https://app.cochat.ai/papers/10.1038/s41598-017-03226-6
The paper
Zhao, M., Li, M., Yang, Y., Guo, Z., Sun, Y., Shao, C., Li, M., Sun, W., & Gao, Y. (2017). A comprehensive analysis and annotation of human normal urinary proteome. Scientific Reports. https://doi.org/10.1038/s41598-017-03226-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.